Exabis Library
Welcome to the e-CCO Library!
P457: Long-term follow-up of patients with IBD after switching from original adalimumab to adalimumab biosimilar during COVID 19 pandemic
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P457: Rapid faecal calprotectin test and symptom index for monitoring the disease activity in colonic IBD
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P457: Treatment duration of ustekinumab in patients with Crohn's disease (CD) and psoriasis (PSO) – real-world evidence from German claims data
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P458 Association between adalimumab serum levels and level of remission in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P458: Effect of cognitive behavioural therapy on clinical disease course in adolescents and young adults with inflammatory bowel disease and subclinical anxiety and/or depression: results of a randomised trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P458: Effectiveness of biological therapy for pouchitis and other inflammatory complications ot the pouch. And the question of a second Anti-TNF after failure? Results from the RESERVO Study of GETECCU.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P458: Long-term outcome of Crohn’s disease complicated by upper gastrointestinal stricture: A GETAID cohort study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P458: Low adherence to Mediterranean diet is associated with increased adipose tissue in patients with ulcerative colitis (UC) after pouch surgery: a cross sectional study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P458: Multidisciplinary working when developing the UK inflammatory bowel disease standards and IBD audit
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P458: Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn's disease (the SPEED-UP study) - A multi-center study from the paediatric IBD Porto group of ESPGHAN
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P458: Sleep problems in inflammatory bowel disease; When bed becomes a battleground
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P459 The impact of latent cytomegalovirus infection on the disease behaviour in patients with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P459: Change in the expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P459: High inadequate surveillance rates in colitis-associated advanced neoplasia: a multicenter retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P459: Hospitalization, use of biologics and surgery rates in inflammatory bowel diseases: a single-center comparative analysis between public and private healthcare systems in a tertiary unit from Latin America
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P459: Obesity in patients with an ileoanal pouch due to ulcerative colitis is not associated with an increased risk for pouchitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P459: Persistent mesorectal inflammatory activity is associated with complications after proctectomy in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P459: Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remission
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P459: Vedolizumab for the treatment of chronic pouchitis: the Edinburgh experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P460 Evaluation of potential mechanisms underlying the safety observations of filgotinib in clinical studies in rheumatoid arthritis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM